Clinical Trial Update: Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab. [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating FOLFOX-4 plus cetuximab versus UFOX plus cetuximab in previously untreated metastatic colorectal cancer; the study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOX-4
• UFOX

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Previously Untreated Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-06-14